loadpatents
name:-0.051350831985474
name:-0.0086071491241455
name:-0.0034060478210449
Protter; Andrew A. Patent Filings

Protter; Andrew A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Protter; Andrew A..The latest application filed is for "treatment of breast cancer".

Company Profile
2.8.20
  • Protter; Andrew A. - San Francisco CA
  • Protter; Andrew A. - Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment of Breast Cancer
App 20210069154 - Protter; Andrew A. ;   et al.
2021-03-11
Treatment of Breast Cancer
App 20190262315 - Protter; Andrew A. ;   et al.
2019-08-29
Treatment of breast cancer
Grant 10,111,861 - Protter , et al. October 30, 2
2018-10-30
Treatment of Breast Cancer
App 20170087132 - Protter; Andrew A. ;   et al.
2017-03-30
Treatment of breast cancer
Grant 9,517,229 - Protter , et al. December 13, 2
2016-12-13
Pyrido[4,3-b]indoles containing rigid moieties
Grant 9,458,155 - Hung , et al. October 4, 2
2016-10-04
Pyrido[4,3-b]indoles Containing Rigid Moieties
App 20150051218 - HUNG; David T. ;   et al.
2015-02-19
Treatment Of Breast Cancer
App 20140296312 - Protter; Andrew A. ;   et al.
2014-10-02
Tetracyclic compounds
Grant 8,338,408 - Hung , et al. December 25, 2
2012-12-25
Tetracyclic compounds
App 20090239854 - HUNG; David T. ;   et al.
2009-09-24
Glycosylated Probnp
App 20080312152 - Pollitt; N. Stephen ;   et al.
2008-12-18
Oxidized Human Bnp
App 20080227713 - Protter; Andrew A.
2008-09-18
Methods Of Promoting Osteogenesis
App 20080108658 - Protter; Andrew A. ;   et al.
2008-05-08
Treatment of pain by inhibition of p38 map kinase
App 20080039461 - Protter; Andrew A. ;   et al.
2008-02-14
Methods of promoting osteogenesis
Grant 7,268,139 - Protter , et al. September 11, 2
2007-09-11
Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase
App 20060058296 - Higgins; Linda S. ;   et al.
2006-03-16
Treatment of multiple myeloma by p38 MAP kinase and proteasome inhibition
App 20060052390 - Schreiner; George F. ;   et al.
2006-03-09
Treatment of obesity and associated conditions with TGF-beta inhibitors
App 20040192583 - Medicherla, Satyanarayana ;   et al.
2004-09-30
Methods for treating diabetes
App 20040171659 - Medicherla, Satyanarayana ;   et al.
2004-09-02
Methods of promoting osteogenesis
App 20040162289 - Protter, Andrew A. ;   et al.
2004-08-19
Methods for improvement of lung function using TGF-beta inhibitors
App 20040146509 - Li, Zhihe ;   et al.
2004-07-29
Treatment of pain by inhibition of p38 MAP kinase
App 20040122008 - Protter, Andrew A. ;   et al.
2004-06-24
Treatment of fibroproliferative disorders using TGF-beta inhibitors
App 20040038856 - Chakravarty, Sarvajit ;   et al.
2004-02-26
Method to treat cystic fibrosis
App 20040009990 - Higgins, Linda S. ;   et al.
2004-01-15
Controlled release delivery of peptide or protein
Grant 6,187,330 - Wang , et al. February 13, 2
2001-02-13
Mature apoai protein production under serum free culturing conditions
Grant 4,943,527 - Protter , et al. July 24, 1
1990-07-24
Company Registrations
SEC0001375580Protter Andrew A

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed